The 2 analysts offering 12-month price forecasts for TRACON Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 1.00. The median estimate represents a +1,150.00% increase from the last price of 0.16.
The current consensus among 3 polled investment analysts is to Buy stock in TRACON Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.04
Reporting Date Nov 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.